A combination of complexation and self-nanoemulsifying drug delivery system for enhancing oral bioavailability and anticancer efficacy of curcumin

References

• American Cancer Society, Key Statistics for Breast Cancer. 2015. Available from: http://www.cancer.org/cancer/breastcancer/detailed guide breast-cancer-key-statistics> [last accessed 7 Aug 2015].
   Google Scholar
• Liao GS, Apaya MK, Shyur LF. Herbal medicine and acupuncture for breast cancer palliative care and adjuvant therapy. Evid Based Complement Alternat Med 2013;2013:437948.
   PubMed Web of Science ®Google Scholar
• Nagaraju GP, Aliya S, Zafar SF, et al. The impact of curcumin on breast cancer. Integr Biol (Camb) 2012;4:996–1007.
   PubMed Web of Science ®Google Scholar
• Yallapu MM, Jaggi M, Chauhan SC. Curcumin nanomedicine: a road to cancer therapeutics. Curr Pharm Des 2013;19:1994–2010.
   PubMed Web of Science ®Google Scholar
• Cui J, Yu B, Zhao Y, et al. Enhancement of oral absorption of curcumin by self-microemulsifying drug delivery systems. Int J Pharm 2009;371:148–55.
   PubMed Web of Science ®Google Scholar
• Cuomo J, Appendino G, Dern AS, et al. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod 2011;74:664–9.
   PubMed Web of Science ®Google Scholar
• Neslihan Gursoy R, Benita S. Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs. Biomed Pharmacother 2004;58:173–82.
   PubMed Web of Science ®Google Scholar
• Liu A, Lou H, Zhao L, Fan P. Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin. J Pharm Biomed Anal 2006;40:720–7.
   PubMed Web of Science ®Google Scholar
• Craig DQM, Barker SA, Banning D, Booth SW. An investigation into the mechanisms of self-emulsification using particle size analysis and low frequency dielectric spectroscopy. Int J Pharm 1995;114:103–10.
   Web of Science ®Google Scholar
• Marasini N, Yan YD, Poudel BK, et al. Development and optimization of self-nanoemulsifying drug delivery system with enhanced bioavailability by Box–Behnken design and desirability function. J Pharm Sci 2012;101:4584–96.
   PubMed Web of Science ®Google Scholar
• Zhang J, Peng Q, Shi S, et al. Preparation, characterization, and in vivo evaluation of a self-nanoemulsifying drug delivery system (SNEDDS) loaded with morin-phospholipid complex. Int J Nanomed 2011;6:3405–14.
   PubMed Web of Science ®Google Scholar
• Jaiswal P, Aggarwal G, Harikumar SL, Singh K. Development of self-microemulsifying drug delivery system and solid-self-microemulsifying drug delivery system of telmisartan. Int J Pharm Investig 2014;4:195–206.
   PubMedGoogle Scholar
• Yamaoka K, Nakagawa T, Uno T. Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations. J Pharmacokinet Biopharm 1978;6:165–75.
   PubMedGoogle Scholar
• Schwarz G. Estimating the dimension of a model. Ann Stat 1978;6:461–4.
   Web of Science ®Google Scholar
• Maiti K, Mukherjee K, Gantait A, et al. Curcumin–phospholipid complex: preparation, therapeutic evaluation and pharmacokinetic study in rats. Int J Pharm 2007;330:155–63.
   PubMed Web of Science ®Google Scholar
• Singh G, Pai RS. Trans-resveratrol self-nano-emulsifying drug delivery system (SNEDDS) with enhanced bioavailability potential: optimization, pharmacokinetics and in situ single pass intestinal perfusion (SPIP) studies. Drug Deliv 2014;11:1–9.
   Web of Science ®Google Scholar
• Neerati P, Sudhakar YA, Kanwar JR. Curcumin regulates colon cancer by inhibiting P-glycoprotein in in-situ cancerous colon perfusion rat model. J Cancer Sci Ther 2013;5:313–19.
   PubMedGoogle Scholar
• Akhtar N, Talegaonkar S, Khar RK, Jaggi M. Self-nanoemulsifying lipid carrier system for enhancement of oral bioavailability of etoposide by P-glycoprotein modulation: in vitro cell line and in vivo pharmacokinetic investigation. J Biomed Nanotechnol 2013;9:1216–29.
   PubMed Web of Science ®Google Scholar
• Chang CC, Fu CF, Yang WT, et al. The cellular uptake and cytotoxic effect of curcuminoids on breast cancer cells. Taiwan J Obstet Gynecol 2012;51:368–74.
   PubMed Web of Science ®Google Scholar
• Peng XC, Yang L, Yang LP, et al. Efficient inhibition of murine breast cancer growth and metastasis by gene transferred mouse survivin Thr34-&→Ala mutant. J Exp Clin Cancer Res 2008;27:46.
   PubMed Web of Science ®Google Scholar
• Wei X, Senanayake TH, Bohling A, Vinogradov SV. Targeted nanogel conjugate for improved stability and cellular permeability of curcumin: synthesis, pharmacokinetics, and tumor growth inhibition. Mol Pharm 2014;11:3112–22.
   PubMed Web of Science ®Google Scholar
• Som I, Bhatia K, Yasir M. Status of surfactants as penetration enhancers in transdermal drug delivery. J Pharm Bioallied Sci 2012;4:2–9.
   PubMedGoogle Scholar
• Pouton CW. Self-emulsifying drug delivery systems: assessment of the efficiency of emulsification. Int J Pharm 1985;27:335–48.
   Web of Science ®Google Scholar
• Davies B, Morris T. Physiological parameters in laboratory animals and humans. Pharm Res 1993;10:1093–5.
   PubMed Web of Science ®Google Scholar
• Xie X, Tao Q, Zou Y, et al. PLGA nanoparticles improve the oral bioavailability of curcumin in rats: characterizations and mechanisms. J Agric Food Chem 2011;59:9280–9.
   PubMed Web of Science ®Google Scholar
• Prabhakar K, Afzal SM, Surender G, Kishan V. Tween 80 containing lipid nanoemulsions for delivery of indinavir to brain. Acta Pharm Sin B 2013;3:345–53.
   Web of Science ®Google Scholar
• Karunagaran D, Rashmi R, Kumar TR. Induction of apoptosis by curcumin and its implications for cancer therapy. Curr Cancer Drug Targets 2005;5:117–29.
   PubMed Web of Science ®Google Scholar
• Cridge BJ, Larsen L, Rosengren RJ. Curcumin and its derivatives in breast cancer: current developments and potential for the treatment of drug-resistant cancers. Oncol Discov 2013;1. doi: http://dx.doi.org/10.7243/2052-6199-1-6.
   Google Scholar
• Ma J, Guo Y, Chen S, et al. Metformin enhances tamoxifen-mediated tumor growth inhibition in ER-positive breast carcinoma. BMC Cancer 2014;14:172.
   PubMed Web of Science ®Google Scholar
• Sun L, Deng X, Yang X, et al. Co-delivery of doxorubicin and curcumin by polymeric micelles for improving antitumor efficacy on breast carcinoma. RSC Adv 2014;4:46737–50.
   Web of Science ®Google Scholar